Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms
NCT01909128 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 405
Last updated 2015-03-19
Summary
The respiratory and gastrointestinal infections are a very common problem with high morbidity in children. These conditions were due, in general, immaturity and all "inexperience" of the immune system, as well as to the particular anatomical structure and function of the respiratory and gastrointestinal tract still developing. This inevitably means that school-age children develop disease (as a result of infection) more easily than at later ages. The frequency and duration of these conditions implies a high discomfort and incur significant costs in relation to drug administration, the need for hospitalization, days of absence from school and work days lost by parents.
Recently probiotics, defined as "microorganisms that prove able, once ingested in adequate amounts, exert beneficial functions for the body "have been proposed for the treatment of treatment of respiratory and gastrointestinal infections of childhood but only in recent years have been conducted controlled clinical trials that have conclusively proven effectiveness. All probiotics induce an immune response, the characteristics of which are related to the strain or the mixture of bacteria used. Recent studies have demonstrated positive effects of probiotics on the respiratory system, and in particular on the prevention and reduction of the severity of respiratory infections, probably mediated by an increase of cells that secrete Immunoglobulin A in bronchial mucosa. It 'been shown that probiotics can be a sure way to reduce the risk of early acute otitis media and the use of antibiotics for recurrent respiratory infections during the first year of life. Similar results were seen in a study conducted on a population of 326 children aged between 3 and 5 years, who found a decrease in the incidence of antibiotic use by over 65% and a reduction of days of absence of more than 25% among children treated with a probiotic. Many of the studied effects of probiotics, understandably, refer to the digestive system. These effects relate to both conditions paraphysiological (constipation) and more specifically in situations of illness.
Most of the studies carried out in recent years has demonstrated the efficacy of specific probiotics in reducing the symptoms in the pediatric population affected by infectious gastroenteritis. Probiotics reduce the duration of infectious diarrhea by 0.7 days and reduce the frequency of diarrheal episodes in the first few hours.
The microbiota on the other hand participates in the function of the mucosal barrier against the adhesion of pathogenic bacteria, crucial time for the start of the infectious process.
When this barrier function is altered by chemical agents, by antigens or by stressors of different nature, may manifest intestinal disorders, sometimes due to the growth of bacteria pathogens. Numerous experimental data suggest that probiotics can contribute to the reinforcement of the activities of gut mucosal barrier, in particular aspects affecting the functionality of the intestinal epithelial cells or macrophages.
More recently it has been shown that daily intake for 3 months of preparation with probiotics reduce the incidence and severity of the most common respiratory infections and limits the number of days of absence school children during the winter season.
It's scientifically recognized as some probiotic effects can also be obtained with the use of inactivated bacteria or bacterial components isolated (eg bacterial DNA). It has been recently proposed a modified definition of probiotic products as "prepared bacterial cells or bacterial components that have a beneficial effect on the health and welfare of the host".
Among these products "probiotic-like" fall ingredients object of this study: food ingredients (rice flour and skim milk) fermented, or in which has been made to grow a probiotic (Lactobacillus CBA-L74) that has been inactivated at the end of the fermentation process through a heat treatment. The benefits are attributable to bacterial components that remain in the final product (for example, DNA, cell wall, etc.) and factors produced during the fermentation (short chain fatty acids, bacterial proteins, etc.).
The main effects of these bacterial components relate to the stimulation of the gastrointestinal tract associated lymphoid tissue (GALT), through interaction with the immune cells via Toll-like receptors.
In addition, some components, such as proteins and peptides, may have a Bifidogenic activity and are available in the literature some studies that have demonstrated the ability of infant formula, milk-based fermented to reduce the severity of episodes of infectious diarrhea in children.
With this data, the Commission of the European Society of Nutrition Gastroenterology, Hepatology and Pediatric Nutrition (ESPGHAN) has defined this type of products are not only safe but to determine a potential prebiotic effect and the reduction of the severity of episodes of infectious diarrhea.
Conditions
- Gastrointestinal Infections
- Respiratory Infections
Interventions
- DIETARY_SUPPLEMENT
-
fermented milk
fermented milk with Lactobacillus CBA-L74
- DIETARY_SUPPLEMENT
-
fermented rice
fermented rice wit Lactobacillus CBA-L74
Sponsors & Collaborators
-
Federico II University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 12 Months
- Max Age
- 48 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NCT06212427 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy
NCT07197814 ·Status: RECRUITING ·Phase: NA
-
Effect of Oligosaccharides and Optimizing Multiple Nutrients to Infant Formula on Growth and Development of Infants
NCT06569797 ·Status: RECRUITING ·Phase: NA
-
Regulation and Mechanism of New Compound Functional Ingredients in Infants
NCT05297006 ·Status: UNKNOWN
-
Effect Of Lactobacillus GG on Atopic March
NCT01891916 ·Status: UNKNOWN ·Phase: NA
-
First Complementary Foods and the Infant Gastrointestinal Microbiota
NCT05492253 ·Status: COMPLETED ·Phase: NA
-
Effects of Infant Formula Composition on Infant Feeding Behaviors
NCT00957892 ·Status: COMPLETED
-
Early Administration of Lactose-free Milk in Children Presenting With Acute Diarrhea
NCT01269892 ·Status: COMPLETED ·Phase: PHASE2
-
Lactose, Sucrose & Corn Syrup Tolerance
NCT01789307 ·Status: COMPLETED ·Phase: NA
-
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
NCT01622426 ·Status: COMPLETED ·Phase: NA
-
An Exploratory RWE Study Exploring Effects of a Goat Milk Based Young Child Formula on Health Benefits
NCT06287385 ·Status: COMPLETED ·Phase: NA
-
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
NCT02379598 ·Status: COMPLETED
-
Effects of Raw Versus Other Milk Sources on Lactose Digestion
NCT01129791 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants
NCT03163212 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides (HMOs) in Preterm Infants
NCT03607942 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil
NCT01431469 ·Status: COMPLETED ·Phase: NA
-
Tolerability of Hypoallergenic Formula in Children With Cow's Milk Allergy
NCT03909113 ·Status: COMPLETED ·Phase: NA
-
Feeding Intolerance in Formula-Fed Infants
NCT02028156 ·Status: TERMINATED ·Phase: NA
-
Immunity Modification of Full Term Infants According to the Type of Feeding and Mode of Delivery
NCT03637894 ·Status: COMPLETED ·Phase: NA
-
Study on the Induction of Food Tolerance in Babies
NCT02825069 ·Status: COMPLETED ·Phase: NA
-
Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties
NCT00859092 ·Status: COMPLETED ·Phase: PHASE2
-
Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
NCT00977912 ·Status: TERMINATED ·Phase: NA
-
Effect of a New Growing-up Milk on Growth and Nutrient Adequacy in Children With Picky-eating Behaviors
NCT01823302 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age
NCT01488435 ·Status: COMPLETED ·Phase: NA
-
Interaction Between Dairy and Gut Hormone Response on Cognitive Performance in Children.
NCT07231146 ·Status: RECRUITING ·Phase: NA